{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:42:50Z","timestamp":1790473370050,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T00:00:00Z","timestamp":1548720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Merck & Co., Inc., Kenilworth, NJ USA","award":["IISP#39298"],"award-info":[{"award-number":["IISP#39298"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12944-019-0974-y","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T22:03:02Z","timestamp":1548799382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy"],"prefix":"10.1186","volume":"18","author":[{"given":"Xiaowei","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,29]]},"reference":[{"key":"974_CR1","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","volume":"137","author":"Z Wang","year":"2018","unstructured":"Wang Z, Chen Z, Zhang L, Wang X, Hao G, Zhang Z, Shao L, Tian Y, Dong Y, Zheng C, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015. Circulation. 2018;137:2344\u201356.","journal-title":"Circulation"},{"key":"974_CR2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijcard.2017.12.069","volume":"260","author":"M Zhang","year":"2018","unstructured":"Zhang M, Deng Q, Wang L, Huang Z, Zhou M, Li Y, Zhao Z, Zhang Y, Wang L. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196\u2013203.","journal-title":"Int J Cardiol"},{"key":"974_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7150\/ijms.13456","volume":"13","author":"J Liu","year":"2016","unstructured":"Liu J, Ma J, Wang J, Zeng DD, Song H, Wang L, Cao Z. Comorbidity analysis according to sex and age in hypertension patients in China. Int J Med Sci. 2016;13:99\u2013107.","journal-title":"Int J Med Sci"},{"key":"974_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/HYPERTENSIONAHA.114.04310","volume":"65","author":"P Verdecchia","year":"2015","unstructured":"Verdecchia P, Reboldi G, Angeli F, Trimarco B, Mancia G, Pogue J, Gao P, Sleight P, Teo K, Yusuf S. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension. 2015;65:108\u201314.","journal-title":"Hypertension"},{"key":"974_CR5","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1053\/euhj.2001.2888","volume":"23","author":"F Thomas","year":"2002","unstructured":"Thomas F, Bean K, Guize L, Quentzel S, Argyriadis P, Benetos A. Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women. Eur Heart J. 2002;23:528\u201335.","journal-title":"Eur Heart J"},{"key":"974_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1524-6175.2007.06518.x","volume":"9","author":"VA Lopez","year":"2007","unstructured":"Lopez VA, Franklin SS, Tang S, Wong ND. Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension. J Clin Hypertens (Greenwich). 2007;9:436\u201343.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"974_CR7","doi-asserted-by":"crossref","unstructured":"Yusuf S, Lonn E, Pais P, Bosch J, L\u00f3pez-Jaramillo P, Zhu J, Xavier D, Avezum A, Leiter LA, Piegas LS, et al. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease. N Engl J Med. 2016;374:2032-43.","DOI":"10.1056\/NEJMoa1600177"},{"key":"974_CR8","doi-asserted-by":"publisher","first-page":"e62469","DOI":"10.1371\/journal.pone.0062469","volume":"8","author":"H Wang","year":"2013","unstructured":"Wang H, Zhang X, Zhang J, He Q, Hu R, Wang L, Su D, Xiao Y, Pan J, Ye Z. Factors associated with prevalence, awareness, treatment and control of hypertension among adults in southern China: a community-based, cross-sectional survey. PLoS One. 2013;8:e62469.","journal-title":"PLoS One"},{"key":"974_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2471\/BLT.13.124495","volume":"92","author":"XL Feng","year":"2014","unstructured":"Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China health and retirement longitudinal study. Bull World Health Organ. 2014;92:29\u201341.","journal-title":"Bull World Health Organ"},{"key":"974_CR10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.atherosclerosis.2014.05.916","volume":"235","author":"S Zhao","year":"2014","unstructured":"Zhao S, Wang Y, Mu Y, Yu B, Ye P, Yan X, Li Z, Wei Y, Ambegaonakr BM, Hu D, Investigators DY-CS. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia international study (DYSIS). Atherosclerosis. 2014;235:463\u20139.","journal-title":"Atherosclerosis"},{"key":"974_CR11","first-page":"579","volume":"39","author":"LS Liu","year":"2011","unstructured":"Liu LS. Hypertension WGoCGftMo: [2010 Chinese guidelines for the management of hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39:579\u2013615.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"974_CR12","first-page":"723","volume":"47","author":"DY Hu","year":"2008","unstructured":"Hu DY, Ding RJ. Guidelines for management of adult dyslipidemia in China. Zhonghua Nei Ke Za Zhi. 2008;47:723\u20134.","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"974_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/2230-8210.93742","volume":"16","author":"JJ Dalal","year":"2012","unstructured":"Dalal JJ, Padmanabhan TN, Jain P, Patil S, Vasnawala H, Gulati A. LIPITENSION: interplay between dyslipidemia and hypertension. Indian J Endocrinol Metab. 2012;16:240\u20135.","journal-title":"Indian J Endocrinol Metab"},{"key":"974_CR14","first-page":"554","volume":"30","author":"ZR Guo","year":"2009","unstructured":"Guo ZR, Hu XS, Wu M, Zhou MH, Zhou ZY. A prospective study on the association between dyslipidemia and hypertension. Zhonghua Liu Xing Bing Xue Za Zhi. 2009;30:554\u20138.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"974_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/01.HYP.0000196306.42418.0e","volume":"47","author":"RO Halperin","year":"2006","unstructured":"Halperin RO, Sesso HD, Ma J, Buring JE, Stampfer MJ, Gaziano JM. Dyslipidemia and the risk of incident hypertension in men. Hypertension. 2006;47:45\u201350.","journal-title":"Hypertension"},{"key":"974_CR16","doi-asserted-by":"crossref","first-page":"e003053","DOI":"10.1161\/JAHA.115.003053","volume":"4","author":"T Otsuka","year":"2016","unstructured":"Otsuka T, Takada H, Nishiyama Y, Kodani E, Saiki Y, Kato K, Kawada T. Dyslipidemia and the risk of developing hypertension in a working-age male population. J Am Heart Assoc. 2016;4:e003053.","journal-title":"J Am Heart Assoc"},{"key":"974_CR17","first-page":"252","volume":"39 Supplement","author":"HJ Li","year":"2011","unstructured":"Li HJ, Liu J, Guo XY, Zhao D. Status of Outpatients in Hypertension Combined with Multiple Cardiovascular Risk Factors in China--CONSIDER Study. Chin J Cardiol. 2011;39 Supplement:252.","journal-title":"Chin J Cardiol"},{"key":"974_CR18","first-page":"e128","volume":"33 Suppl 1","author":"X Zhang","year":"2015","unstructured":"Zhang X, Feldmam R, Wu Z, Zhang Y, Yu X, Liu L. Lb03.09: Therapeutic Inertia Is a Major Determinant of Bp Control Rates in China. A Hypertension Attitude Perspectives and Needs (Happen) Study Report. J Hypertens. 2015;33 Suppl 1:e128.","journal-title":"J Hypertens"},{"key":"974_CR19","first-page":"e124","volume":"33 Suppl 1","author":"J Wang","year":"2015","unstructured":"Wang J, Song J, Huang QF, Li LH, Sheng CS, Li Y, Ji LN, Kang Y. Comparison between Cardiology and Endocrinology Physicians in Their Management of Hypertension and Diabetes Mellitus: A China Registry. J Hypertens. 2015;33 Suppl 1:e124.","journal-title":"J Hypertens"},{"key":"974_CR20","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2165\/11597410-000000000-00000","volume":"12","author":"BK Hong","year":"2012","unstructured":"Hong BK, Park CG, Kim KS, Yoon MH, Yoon HJ, Yoon JH, Yang JY, Choi YJ, Cho SY. Comparison of the efficacy and safety of fixed-dose amlodipine\/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study. Am J Cardiovasc Drugs. 2012;12:189\u201395.","journal-title":"Am J Cardiovasc Drugs"},{"key":"974_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","volume":"122","author":"DS Wald","year":"2009","unstructured":"Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290\u2013300.","journal-title":"Am J Med"},{"key":"974_CR22","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/MNH.0b013e328356c551","volume":"21","author":"AH Gradman","year":"2012","unstructured":"Gradman AH. Strategies for combination therapy in hypertension. Curr Opin Nephrol Hypertens. 2012;21:486\u201391.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"974_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1758-5996-2-44","volume":"2","author":"S Kalra","year":"2010","unstructured":"Kalra S, Kalra B, Agrawal N. Combination therapy in hypertension: an update. Diabetol Metab Syndr. 2010;2:44.","journal-title":"Diabetol Metab Syndr"},{"key":"974_CR24","first-page":"701","volume":"37","author":"W Wang","year":"2009","unstructured":"Wang W, Ma LY, Liu MB, Deng Q, Zhang YQ, Li W, Zhu DL, Lin SG, Huang J, Liu LS, Group CC. Effects of amlodipine plus telmisartan or amlodipine plus amiloride regimen on blood pressure control in hypertensive patients: preliminary report of Chinese hypertension intervention efficacy (CHIEF) trial. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37:701\u20137.","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"974_CR25","volume-title":"Report on Cardiovascular Diseases in China 2012","author":"National Center for Cardiovascular Diseases C","year":"2014","unstructured":"National Center for Cardiovascular Diseases C: Report on Cardiovascular Diseases in China 2012. 2014."},{"key":"974_CR26","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","volume":"336","author":"B Vrijens","year":"2008","unstructured":"Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2008;336:1114\u20137.","journal-title":"BMJ"},{"key":"974_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11906-996-0035-6","volume":"2","author":"KA Payne","year":"2000","unstructured":"Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep. 2000;2:515\u201324.","journal-title":"Curr Hypertens Rep"},{"key":"974_CR28","first-page":"e22","volume":"19","author":"B Yu","year":"2013","unstructured":"Yu B, Zhang X, Wang G. Full coverage for hypertension drugs in rural communities in China. Am J Manag Care. 2013;19:e22\u20139.","journal-title":"Am J Manag Care"},{"key":"974_CR29","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/jep.12268","volume":"21","author":"Z Yue","year":"2015","unstructured":"Yue Z, Bin W, Weilin Q, Aifang Y. Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence. J Eval Clin Pract. 2015;21:166\u201372.","journal-title":"J Eval Clin Pract"},{"key":"974_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fphar.2017.00100","volume":"8","author":"B Vrijens","year":"2017","unstructured":"Vrijens B, Antoniou S, Burnier M, de la Sierra A, Volpe M. Current situation of medication adherence in hypertension. Front Pharmacol. 2017;8:100.","journal-title":"Front Pharmacol"},{"key":"974_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00392-010-0114-1","volume":"99","author":"MC Wong","year":"2010","unstructured":"Wong MC, Jiang JY, Su X, Wang H, Tang JL, Griffiths SM. Individuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patients. Clin Res Cardiol. 2010;99:277\u201384.","journal-title":"Clin Res Cardiol"},{"key":"974_CR32","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.hrtlng.2014.05.001","volume":"43","author":"W Wang","year":"2014","unstructured":"Wang W, Lau Y, Loo A, Chow A, Thompson DR. Medication adherence and its associated factors among Chinese community-dwelling older adults with hypertension. Heart Lung. 2014;43:278\u201383.","journal-title":"Heart Lung"},{"key":"974_CR33","first-page":"191","volume":"5","author":"Y Liu","year":"2015","unstructured":"Liu Y, Li H, Hong S, Yin X. Salt reduction and hypertension in China: a concise state-of-the-art review. Cardiovasc Diagn Ther. 2015;5:191\u20136.","journal-title":"Cardiovasc Diagn Ther"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-0974-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-019-0974-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-019-0974-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T03:06:02Z","timestamp":1662865562000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-019-0974-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,29]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["974"],"URL":"https:\/\/doi.org\/10.1186\/s12944-019-0974-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,29]]},"assertion":[{"value":"13 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Our study was performed in accordance with the Declaration of Helsinki with regard to ethical principles for research involving human subjects. All patients provided informed written consent before beginning the study and the Ethics Committee of each clinic center approved the protocols.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from all enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"32"}}